Clinical Trial Update: Open Label Immunotherapy of Myoma [Phase 2]

View source ↗

Summary

This document reports an open-label Phase 2 clinical trial evaluating immunotherapy for uterine fibroids (myoma) conducted by Immunitor LLC; no results are prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyoma of Uterus
• Uterine Fibroids

Drugs mentioned

• Immunotherapy (immunotherapy)

Snippet

Sponsor: Immunitor LLC | Conditions: Myoma;Uterus, Fibroid Uterus | Phase 2 | Status: UNKNOWN